SCHEMBL20050109

SCHEMBL20050109

CCN(C(C)C)C(C)C(C(=O)[C@H](CNc1ncnc(Cl)c1N)NC(=O)OC(C)(C)C)C(C)P(F)(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.32
SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580317 0.76 PPARA (0.41) EGFRSYK
SCHEMBL15956011 0.76 PPARA (0.41) EGFRSYK
SCHEMBL20050106 0.76 SYK (0.39) EGFRSYK
SCHEMBL3577414 0.71 CACNA1B (0.47) EGFRSYK
SCHEMBL31398897 0.67 PPARA (0.41) EGFRSYK
SCHEMBL31398893 0.65 TRPA1 (0.38) EGFRSYK
SCHEMBL21591579 0.64 STK17B (0.60)
SCHEMBL30132335 0.64 STK17B (0.60)
SCHEMBL31398957 0.63 SYK (0.43) EGFRSYK
SCHEMBL31398924 0.63 SYK (0.43) EGFRSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180098998-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098998-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS CNKSR1, ARAF, MAP4K2 EGFR 478/4885SYK 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.